FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

Bayer Wins FDA Clearance of myBETAapp and Betaconnect Navigator

June 1, 2017

The FDA has approved Bayer’s supplemental Biologics License Application for myBETAapp and the Betaconnect navigator.

The autoinjector is used to administer Betaseron (interferon beta-1b) which uses bluetooth to connect the autoinjector to the new myBETAapp on a mobile device or computer.

Betaseron is a prescription medicine used to reduce relapses in individuals with relapsing forms of multiple sclerosis. — Cynthia Jessup

View today's stories